Literature DB >> 10843732

IL-4-dependent induction of BCL-2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3-kinase-independent pathway.

M A Aronica1, S Goenka, M Boothby.   

Abstract

Both B and T lymphocytes require ongoing signals to maintain their viability. The pleiotropic cytokine interleukin (IL-) 4 plays an important role in the maintenance of activated T cells, perhaps reflecting induction of the anti-apoptotic genes Bcl-2 and Bcl-X(L). However, it is not known which of the signalling pathways known to link the IL-4 receptor with transcription regulation are required, or if the levels of Bcl-2/X induction under such physiologic conditions are sufficient to account for the anti-apoptotic effects of IL-4. We report here that although blockade of pathways (PI 3-kinase and pp70 S6 kinase) recruited by the IRS-1/2 adaptor proteins inhibited the anti-apoptotic function of IL-4, Bcl-2/X induction were normal. These findings were recapitulated in primary and culture-adapted T cells whose Stat6 signalling pathway also was defective. These results demonstrate that both the Stat6 and PI 3-kinase pathways can be dispensable for Bcl-2/X induction by IL-4, thus suggesting the involvement of an additional signal transduction pathway. Moreover, the preservation of Bcl-2/X induction despite inhibition of the anti-apoptotic function of IL-4 indicates that this cytokine activates additional protective mechanisms. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843732     DOI: 10.1006/cyto.1999.0603

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

Review 1.  IL-4 signaling, gene transcription regulation, and the control of effector T cells.

Authors:  M Boothby; A L Mora; M A Aronica; J Youn; J R Sheller; S Goenka; L Stephenson
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Integration of cytokine and heterologous receptor signaling pathways.

Authors:  Jelena S Bezbradica; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

3.  An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

Authors:  Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

4.  T-cell homeostasis in mice exposed to airborne xenobiotics.

Authors:  Nadzieja Drela; Justyna Bień; Ewa Kozłowska
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

5.  PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells.

Authors:  Sung Hoon Cho; Shreevrat Goenka; Tiina Henttinen; Prathyusha Gudapati; Arja Reinikainen; Christine M Eischen; Riitta Lahesmaa; Mark Boothby
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

6.  Suppression of Foxo1 activity and down-modulation of CD62L (L-selectin) in HIV-1 infected resting CD4 T cells.

Authors:  Benjamin Trinité; Chi N Chan; Caroline S Lee; Saurabh Mahajan; Yang Luo; Mark A Muesing; Joy M Folkvord; Michael Pham; Elizabeth Connick; David N Levy
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

7.  Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression.

Authors:  Matteo Paccagnella; Andrea Abbona; Andrea Michelotti; Elena Geuna; Fiorella Ruatta; Elisabetta Landucci; Nerina Denaro; Paola Vanella; Cristiana Lo Nigro; Danilo Galizia; Marco Merlano; Ornella Garrone
Journal:  Vaccines (Basel)       Date:  2022-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.